Pfizer Laboratories Div Pfizer IncUsage: Zirabev treats metastatic colorectal cancer, first-line non-squamous non-small cell lung cancer, recurrent glioblastoma in adults, metastatic renal cell carcinoma, persistent/recurrent/metastatic cervical cancer, and epithelial ovarian, fallopian tube, or primary peritoneal cancer. Used in combination with chemotherapy or as single-agent maintenance.